Arie Belldegrun, M.D.

Arie Belldegrun, M.D.

Chair of the BoardatAllogene Therapeutics· In proxies 2023–2025

Arie Belldegrun, M.D. sits on 8 public boards.

Experience

  1. Allogene TherapeuticsPublic company · 2 yr
    • Chair of the Board2024 – Present · 2 yrStock in role -58%
  2. Ginkgo Bioworks HoldingsPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  3. Breakthrough Services LLCPublic company · 7 yr
    • Director2019 – Present · 7 yrNo stock prices for these years
  4. ByHeart, Inc.Public company · 7 yr
    • Director2019 – Present · 7 yrNo stock prices for these years
  5. Allogene Therapeutics, Inc.Public company
    • Director? – PresentNo stock prices for these years
  6. Breakthrough Properties LLCPublic company
    • Director? – PresentNo stock prices for these years
  7. Kronos Bio, Inc.Public company
    • Director? – PresentNo stock prices for these years
  8. UroGen Pharma, Ltd.Public company
    • Director? – PresentNo stock prices for these years
  9. IconOVir Bio, Inc.Public company · 5 yr
    • Director2020 – 2025 · 5 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?